Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Collider bias can distort our understanding of COVID-19 risk and severity.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

The study found that in Latin America, ancestry varies by location, influences physical traits, and affects how people perceive their own heritage.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Growing human skin cells in a 3D environment can stimulate new hair growth.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Nanozymes greatly improve biocatalysis by being stable, efficient, and versatile.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Hedgehog signaling is crucial for mammary gland development over hair follicles.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

The hepatitis B vaccine did not cause hair loss in the tested mice.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The conclusion is that balancing cost and carbon emissions in hybrid power systems is crucial, especially when high reliability is needed, but the model needs to consider all device efficiencies and distribution losses.